This afternoon we watched CVS Health drop -2.6% to a price of $69.5 per share. The large-cap Pharmaceutical Retail company is now trading -23.24% below its average target price of $90.54. Analysts have set target prices ranging from $76.0 to $110.0 per share for CVS Health, and have given the stock an average rating of buy.
CVS Health's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.2%. The stock's short ratio is 1.61. The company's insiders own 0.18% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 79.9%. In conclusion, we believe there is mixed market sentiment regarding CVS Health.
Institutions Invested in CVS Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-06-30 | Vanguard Group Inc | 9% | 116,676,882 | $8,109,054,871 |
| 2023-06-30 | Blackrock Inc. | 7% | 93,734,850 | $6,514,581,371 |
| 2023-06-30 | State Street Corporation | 4% | 55,877,387 | $3,883,483,938 |
| 2023-06-30 | Morgan Stanley | 3% | 33,253,424 | $2,311,116,266 |
| 2023-06-30 | Capital World Investors | 2% | 30,490,802 | $2,119,113,763 |
| 2023-06-30 | Geode Capital Management, LLC | 2% | 23,325,287 | $1,621,109,759 |
| 2023-06-30 | FMR, LLC | 2% | 21,292,797 | $1,479,851,503 |
| 2023-06-30 | Invesco Ltd. | 1% | 17,002,487 | $1,181,674,532 |
| 2023-06-30 | Bank of America Corporation | 1% | 16,551,119 | $1,150,304,412 |
| 2023-06-30 | Dodge & Cox Inc | 1% | 16,024,422 | $1,113,698,918 |
